MLH1 and Lynch syndrome: Colorectal cancer patients with suspected Lynch syndrome, who were selected for epimutation tests because of negative germline tests for MMR genes, had MSI and IHC loss of MLH1 due to epimutation at rates of 3%–10% [11,13,14,16,17,29,30,31,32,33].